Bacterial ceramide synthesis (Caulobacter vibrioides)
From WikiPathways
Description
This pathway depicts the bacterial ceramide synthesis; bacteria are known to produces various groups of sphingolipids. This lipid class holds several physiological functions. In the human microbiome, commensal and pathogenic bacteria use sphingolipids to mimic the inflammatory system of the host.
Several key eukaryotic ceramide synthesis enzymes have no bacterial homologue, which creates a challenge in understanding their biosynthetic pathway(s).
Quality Tags
Ontology Terms
Bibliography
- Stankeviciute G, Tang P, Ashley B, Chamberlain JD, Hansen MEB, Coleman A, D'Emilia R, Fu L, Mohan EC, Nguyen H, Guan Z, Campopiano DJ, Klein EA; ''Convergent evolution of bacterial ceramide synthesis.''; Nat Chem Biol, 2022 PubMed Europe PMC Scholia
- Peter J. Harrison, Teresa M. Dunn, Dominic J. Campopiano; ''Sphingolipid biosynthesis in man and microbes''; Nat. Prod. Rep., 2018 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
3-ketosphinganine | Metabolite | LMSP01020002 (LIPID MAPS) | |
Acyl-CoA | Metabolite | LMFA07050000 (LIPID MAPS) | |
CerR | GeneProduct | A0A0H3C8X7 (Uniprot-TrEMBL) | |
CoA | Metabolite | 15346 (ChEBI) | |
L-Serine | Metabolite | 17115 (ChEBI) | |
Long-chain FA-CoA Ligase | GeneProduct | A0A0H3C6D9 (Uniprot-TrEMBL) | |
N-acyl-3-oxosphinganine | Metabolite | LMSP02080000 (LIPID MAPS) | |
N-acyl-sphinganine | Metabolite | LMSP02020000 (LIPID MAPS) | |
Palmitic acid | Metabolite | LMFA01010001 (LIPID MAPS) | |
Palmitoyl-CoA | Metabolite | LMFA07050360 (LIPID MAPS) | |
SPT | GeneProduct | A0A0H3C7E9 (Uniprot-TrEMBL) | |
bCerS | GeneProduct | A0A0H3C8X0 (Uniprot-TrEMBL) |
Annotated Interactions
No annotated interactions